Add to Favourites
To login click here
A team of researchers at Ecole Polytechnique Fédérale de Lausanne have used deep learning to design synthetic soluble versions of cell membrane proteins, making them easier to work with and less expensive to produce. This allows for more efficient drug and antibody discovery pathways.